chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Jul2022 at 11:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 36 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing); "ADHD" (unspecified if ongoing); "Vertigo" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa. Concomitant medication(s) included: VENLAFAXINE, start date: 12Apr2022; ZYRTEC [CETIRIZINE HYDROCHLORIDE], start date: 16Sep2020; FLONASE [FLUTICASONE PROPIONATE], start date: 13Jul2021. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Mar2023) Negative, notes: first negative test two days later,; (Mar2023) Positive, notes: I recorded two positive rapid tests; (Mar2023) Positive, notes: I recorded two positive rapid tests. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Patient stopped taking Paxlovid street the second day (treated with PAXLOVID from 13Mar2023 to 15Mar2023) as patient developed severe diarrhea and some vomiting. Patient received her first negative test two days later, then 7 days after Paxlovid patient started having a sore throat, fatigue, and body aches so she tested for COVID-19. She recorded two positive rapid tests.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
By 10am the day after vaccine the fever broke and I was just left with fatigue; 10 hours after vaccine I started with a fever that climbed to 103.3F overnight; This was joined by chills; This was joined by chills and body/joint discomfort as well as headache; body/joint discomfort; headache; This is a spontaneous report from a contactable other healthcare professional (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection lot number: EL8982), intramuscular at left arm on 21Jan2021, 08:15 at single dose for COVID-19 immunization. The patient's medical history included hypothyroidism, penicillins allergy and COVID-19 diagnosed on an unspecified date prior to vaccination. The patient's concomitant medications included levothyroxine, minerals nos, vitamins nos (PRENATAL VITAMIN), and riboflavin. The patient was not pregnant at the time of vaccination. The patient previously received the first dose of BNT162B2 (lot number: EK9231) on 30Dec2020, 12:30 PM at left arm for COVID-19 immunization. The patient has not been tested for COVID-19 since vaccination. On 21Jan2021 18:00 (10 hours after vaccine), the patient started with a fever that climbed to 103.3F overnight. This was joined by chills and body/joint discomfort as well as headache. By 10am the day after vaccine (22Jan2021), the fever broke and she was just left with fatigue. No treatment was given for the events. Facility where the most recent COVID-19 vaccine was administered was at the hospital. The outcome of the events were recovering. The events were non-serious.
Information has been received from a physician via a company representative referring to a 7 month old female patient. Patient's current condition or medical history was not reported. On 12-AUG-2014 the patient was vaccinated with a dose of ROTATEQ (lot# reported as K006455, dose 2 ml, oral). On 07-NOV-2014 the patient was vaccinated with another dose of ROTATEQ (lot# reported as K009182, dose 2 ml, oral). On 26-JAN-2015 the patient was vaccinated with another dose of ROTATEQ (lot# reported as K023530, dose 2 ml, oral). Concomitant medications were not provided. On 02-FEB-2015 the patient experienced diarrhea, vomiting and tested positive for rotavirus. The patient came to the physician's office on 03-FEB-2015 for medical attention. Fluids and other unspecified treatments were given for the events. Therapy was reported as not discontinued. The patient recovered from the events on an unspecified date in February 2015. The causality was not provided. Additional information has been requested.
Projectile vomiting x 3, then dry heaving. Mom giving clear liquids and sprite. Also with fever 101.3 that responds to Motrin.
Patient had 1st vaccine with no issues. Patient had 2nd shot on 2/4/21 at department, and 3rd shot on 8/16/21. After both 2nd and 3rd shot patient has been left with a "skin infection" at the injection site. She reports it as large, hard, red, warm, itchy, and painful. Both times her doctor has prescribed Ciprofloxacin to be taken to clear it up. She reports that the treatment does work. She has diabetes and lupus, and receives many injections that do not cause this type of reaction for her.
13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (13 doses administered 25Oct2021/this lot number has an expiration date of 10/24/2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Oct-2021: Follow-up received includes No new information
C/O difficulty breathing, chest pain & neck pain. Went ER. Diagnosed with pericarditis.
6 weeks aftert having 2nd vaccine I went to the emergency room because of severe vomiting and diarrhea throughtout night. An abdominal CT scan was done and a large blood clot was present in my descending aorta and was sending emboli to both my legs. I was transferred immediately to main hospital and seen by a vasclar team and had emergency surgery to remove emoboli and placed on anticoagulant therapy. I was in SICU for 2 days then went to floor for rest of week. Negative covid test at time and have not tested positive for covid before or after.
Nauseated, it felt like gas that wouldn't go away, felt in back and stomach on the 28th of January that lasted all weekend. Then on the 31st about 6pm in evening, I noticed the rash forming on the front part under my breast on left wrapped around to my back. I then went to the doctor on that Tuesday afternoon 02/01/2022 and was diagnosed with shingles. I was prescribed Valtrex 3 x daily and Gabapentin for pain
PATIENT HAS EXPERIENCED DIZZINESS 5 MINUTES AFTER THE 2ND SHOT.  SHE CAN NOT STAND UP WITHOUT SUPPORT.  SHE'S HAVING PEROID AND HAS NOT EATEN ANYTHING PRIOR COMING FOR HER APPOINTMENT.  PHARMACIST HAS OFFERED HER WATER AND SUPPORTS  WHILE WAITING FOR AMBULANCE ARRIVES.
Patient began to experience palpitations and left-sided chest discomfort approximately 1-2 weeks after the second vaccine dose on 4/22/2021 was received.
Information has been received from a health professional concerning a 20 year old female with no pertinent medical history who on 05-FEB-2007 was vaccinated intramuscularly with a 0.5 ml dose of Gardasil (lot #653650/0702F). There was no concomitant medication. In February 2007, after the vaccination, the patient experienced an "allergic type reaction." The patient developed red raised bumps and itching at the injection site. It was reported that a rash spread to her arms, trunk and legs and the patient experienced a tight chest (she was able to breathe). Medical attention was sought and the patient was treated with a MEDROL DOSEPAK. There were no laboratory or diagnostic tests performed. On 14-FEB-2007, the patient fully recovered. The registered nurse considered red raised bumps and itching at the injection site, rash spread to her arms, trunk and legs and tight chest to be other important medical events. Additional information has been requested.
Seen in office 09/16/2003, 5 varicella vaccine break through rash.  Red papule, few blisters face, legs, arm abdomen, and back.
This spontaneous report as received from a pharmacist refers to a 76 years old female patient. The patient had no drug reactions or allergies. on 28-NOV-2012, the patient was vaccinated with ZOSTAVAX (lot number reported as 0422AB, expiration date 27-MAR-2013), subcutaneous. No other co-suspects were reported. No concomitant medications were reported. On 30-NOV-2012, the patient developed injection site reaction following vaccination. The patient sought medical attention and contacted the pharmacist. The injection site reaction was described as raised, blotchy, red area about 3/4 of inch in diameter (described as a semicircle with a tail on it) that was sore, but not itchy at the injection site. No treatment information was reported. No laboratories were performed. At the time of the report, the patient's outcome for the events was not recovered/not resolved. This is the first of two report from this reporter. Additional information has been requested.
Dizziness while standing up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS POSTURAL (Dizziness while standing up) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced DIZZINESS POSTURAL (Dizziness while standing up). At the time of the report, DIZZINESS POSTURAL (Dizziness while standing up) outcome was unknown.            Concomitant medications were not reported. No treatment medications was reported.
This spontaneous report as received from a licensed vocational nurse refers to a patient of unknown age and gender. No information on patient's medical history, concurrent conditions or concomitant medications was provided. On 11-DEC-2015, the patient was vaccinated with the second dose of VARIVAX injection, lot # K026385, expiration date 15-DEC-2016 (dose and route of administration were not provided) that was improperly stored. No adverse effects were reported. This is one of the several reports from the same source. Additional information has been requested.
tested positive for Covid and have been very sick ever since; tested positive for Covid and have been very sick ever since; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 05Oct2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed; Unknown Manufacturer), for COVID-19 immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2023, outcome "not recovered" and all described as "tested positive for Covid and have been very sick ever since". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Nov2023) positive, notes: tested positive for Covid. Clinical course: The patient tested positive for Covid one month after the vaccination and had been very sick ever since. The patient was fully vaccinated and never had Covid.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300369382 same reporter/drug/event, different patient;
Followed up on 05/09/14 after Tdap (per RN given) on 05/02/14 - left deltoid area red, hard core (3 x 2 cm) surrounded by 7 x 5 soft epidermal erythema. Pain w/ palpation. No fever - responding to warm/cool compresses and ibuprofen.
The decedent received her Moderna Booster at 1:00pm on 11/09/2021. The decedent and her husband arrived home around 2:00pm. The decedent felt fatigued and took a nap. The decedent woke up, ate dinner, and then went for a walk at 7:00pm. After the walk, the decedent felt fatigued and wanted to take a bath to relax. The husband went to check on the decedent at 8:30pm and found the decedent submerged underwater in the bathtub. The decedent was taken to the hospital and was pronounced deceased on 11/11/2021 at 12:31pm.
Patient's arm begin to swell during 15 min waiting  period. No pain was reported, only swelling and redness
After administering vaccines pt immediately broke out into rash and left leg began to swell. MD notified and orders were given by MD for BENADRYL 12.5/5 ml 2.5 ml PO. Medication administered and Pt responded to treatment. Pt released to parents. Pt recovered.
The patient had an adverse reaction to the vaccination and fainted. He began to feel better within 15 minutes of vaccination.
really bad sore arm; headache; chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Apr-2021 and was forwarded to Moderna on 29-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (really bad sore arm), CHILLS (chills) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced CHILLS (chills). On 29-Apr-2021, the patient experienced PAIN IN EXTREMITY (really bad sore arm) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (really bad sore arm), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
07/24/2019 - WED: 7:17 PM PHARMACIST. SHINGRIX VACCiNE IM LEFT ARM. PAiNFUL WHEAL APPEARED iMMEDIATELY. PHARMACIST ADVISED TO PUT iCE ON iT ONCE HOME WHICH I DiD. 07/25/2019-THURS AM WOKE UP EXTREME FATIGUE MUSCLE ACHES, BONE PAIN 7/25 NAUSEOUS, STOMACH UPSET, SHiVERiNG. COULDN'T EAT ALL DAY. TEMP: 101F. LEFT ARM RED, iNFLAMMED 2" DIAMETER AT INJECTION SiTE THAT EVENING A BRIGHT RED RASH APPEARED ON ENTIRE FRONT, BACK, SIDE TORSO. CHEST & UP iNTO NECK, THROAT AREA & DOWN BOTH iNSiDE ARMS. BODY FELT WARM TO TOUCH BUT NO iTCHING OR BREATHiNG DiFFiCULTiES. (TEMP: 100. 6. pm) 07/26/2019- FRiDAY AM: CONTACT DR OFFiCE (MY PHYSICIAN). DR ON VACATION. TOLD TO GO TO 'URGENT CARE CENTER'. 'URGENT CARE' DR. ViTALS: TEMP 97.9 F B/P 136/84 PULSE 94, RESPiR 17, OXYGEN SAT. 98% ADVISED TO TAKE ALLEGRA ANTiHiSTAMiNE: NOT TO HAVE THE 2ND DOSE VACCiNE BECAUSE OF THiS ADVERSE REACTION, QUOTING" WHY TAKE THE CHANCE." PM: ON WAY HOME, STOPPED AT PHARMACiST (DiFFERENT PHARMACIST FROM 24TH) HE SAW MY RASh etc & said I COULD WAiT UP TO 6 months to get 2nd dose  HOWEVER AFTER SEEiNG RASH & HEARD MY REACTIONS, he qUOTED, "I SHOULDN'T TAKE THE CHANCE WITH THE 2ND DOSE IN SERIES" 07/27/2019 - SAT. BODY RASH GONE. TEMP: NORMAL. HOWEVER INJECTION SITE STiLL PAiNFUL 1" diameter 07/28/2019-SUN: BACK TO NORMAL EXCEPT RESiDUAL SORENESS AT VACCiNE SiTE. 07/30/2019 I LEFT PHONE MESSAGE AT VAERS TO FILE 'ADVERSE REACTION REPORT' TO SEND TO MY EMAIL.
Dizziness; Fever; Headache; pain at injection left; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache), VACCINATION SITE PAIN (pain at injection left) and CHILLS (chills) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain at injection left), CHILLS (chills) and FATIGUE (fatigue). On 07-Apr-2021, the patient experienced DIZZINESS (Dizziness), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache), VACCINATION SITE PAIN (pain at injection left), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications  were not reported  Treatment was not specified
- Chills - Sweating - Headache - Full body ache - Tightness in chest - Queasy stomach
08/24/2021 I was very tired, low fever, chills, aches all over, lower back hurt, my nose runny all the time, lasted for about 6 days.
Pain and swelling at base of neck resolved in less than 12 hours. Pain and swelling in elbows, wrists, and hands, then knees, ankles, and feet. Red rash on bilateral forearms. Redness on bilateral hands. Naprosyn 500mg tabs twice a day ordered by Employee/Occupational Health physician for pain and swelling. Follow up visit 3-21-07.
Initial serious health authority (ES-AGEMED-526182232) report received on 18 Mar 2010 and forwarded via license partner (2010-00309) on 18 Mar 2010: This patient received first post-exposure dose of RABIPUR (batch number 441011F) due to dog bite on 03 Jan 2010. The patient also received rabies immuno globulin and AUGMENTIN PLUS for dog bite in Jan 2010. After third dose of RABIPUR vaccine, the patient presented with blurred vision, paraesthesia and dizzy spells on 10 Jan 2010. Then the patient went to the hospital and received fourth dose of RABIPUR in health centre. The patient recovered but still had dizzy spells. The rabies antigen test performed on 25 Jan 2010 in the dog's head but it was negative. Final outcome for the event blurred vision and paraesthesia was reported complete recovery. Outcome for dizzy spells was reported as condition improving.
Pain at site starting at about 6pm the day of the shot. Pain is much better today; just a little sore. Fatigue & muscle pain throughout entire body began the morning after receiving shot & began to subside by about 8pm on May 13.  Fatigue & muscle pain were completely gone by the morning of May 14.
Patient has no adverse events to report at this time. Patient requested Bivalent vaccine and received Monovalent vacine
6-4-2015 about a week after taking PREVNAR 13 arm (left) started hurting. Lost the use of arm did physical therapy it help me to start moving arm again. Pain does not go away limited use of left arm.
Initially had tingling  in left fingers about 30 minutes following injection which resolved with movement of arm, hand and fingers. Fatigue later that evening; 1/6/2021 arm soreness,  fatigue came in waves, muscle soreness, some minor mental confusion; 1/7/2021 temp 99.1, headache, waves of fatique, early to bed slept 12 hours; 1/8-1/11/2021 balance slightly off  plus above issues declining; 1/12/2021 swollen lymph nodes in left armpit, slight soreness  left arm at injection site;  1/13/2021 gradual increased left arm soreness at injection site; 1/14/2021 left arm - red, swollen, warm to touch, painful; contacted provider of injection; 1/15/2021 as above, headache, left hand pins/needles, prescribed dexamethasone daily & cephalexin BID, both for 7 days; 1/16/2021 numbness slightly improved, left hand began to itch, swelling improved slightly, redness improved; 1/17/2021-1/21/2021 gradual improvement continued, swelling in arm disappeared, slight numbness remained; headache & fatigue continued but was improved, very little sleep ~ 3-4 hours nightly;  1/21/2021 saw allergist for recommendations for upcoming 2nd dose - suspected was similar to surgical dye reaction and provided recommendations for next dose. 1/22/2021 finished dexamethasone and cephalexin; slight left hand numbness remained, headache began late in day; 1/23/2021 headache, confusion, anger, balance  continued and worsened through day, both hands &  feet pins/needles; difficulty holding full glass with one hand; extreme fatigue, slept off/on throughout the day; 1/24/2021 as above, left arm sore at injection  site with a hard lump, less anger. vision & hearing off, slight nausea off/on, insides vibrating and won't stop, left side of lower mouth slightly numb, heart racing at times. all symptoms worsen as day progresses; 1/25/2021 as above, left arm stinging at times, very slight improvement with mental confusion; 1/26-1/27/2021 continue to have pins/needles in hands/feet but comes & goes, sleeping 10-14 hours throughout the day; vision & hearing still off, afternoon of 27th had total exhaustion, body like jello, catatonic like state, middle of night awoke with same exhaustion symptoms; 1/28/2021 prescribed  dexamethasone for 14 days, diazepam in AM,  diazepam in PM prn &  citalapram daily; Citalapram caused adverse reaction.
Patient received Pfizer COVID vaccine on 6/21/21 and 9/20/21. On 12/17/21, patient admitted to our facility for COVID-19 pneumonia and weakness. As of today (12/20/21), patient is still admitted in our med/surg unit.
20 minutes after being  vaccinated, patient felt,weak,feeling "I'm going to pass out", facial redness, feeling very hot. Remains alert and oriented x3. Brought to EMT monitoring area, VSS 148/72 HR 57 O2 100%, POC 86, very anxious with husband at bedside. EKG,with heart being monitored all within normal ,noted in database for rate as baseline. Cognitively presents anxious with noting calmness after 30 minutes with patient stating "I just feel not right". Has stated that her throat feeling cold. feeling spacey. Vitals have remained stable and offered to be transported to ER if preferred. Both she and husband agreed to be transported to Hospital. Their son was notified of this episode. Transported in stable condition to Hospital.